Teva's Last Ditch Effort to Save Copaxone Patent

Teva Pharmaceutical Industries has petitioned the US Supreme Court to review a lower court ruling from July 2013 that had cut more than a year off the legal protection for Copaxone.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news